Page last updated: 2024-10-25

desipramine and Brain Damage, Chronic

desipramine has been researched along with Brain Damage, Chronic in 2 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BARRINGER, TJ1
Edwards, WR1

Other Studies

2 other studies available for desipramine and Brain Damage, Chronic

ArticleYear
CLINICAL TRIAL OF DESIPRAMINE IN THE TREATMENT OF DEPRESSION.
    The American journal of psychiatry, 1965, Volume: 121

    Topics: Brain; Brain Damage, Chronic; Brain Injuries; Depression; Depressive Disorder; Desipramine; Drug The

1965
Treatment of poisoning by anti-depressant drugs.
    British medical journal, 1967, Nov-11, Volume: 4, Issue:5575

    Topics: Brain Damage, Chronic; Desipramine; Humans; Hydrocortisone; Infant; Procaine; Thiopental; Urea

1967